Skip to content

Clinical study on applicability of homoeopathic medicine Tarentula hispanica in symptoms of Attention Deficit Hyperactivity Disorder with synthesis repertory

Clinical Verification of Rubrical Representation of Attention Deficit Hyperactivity Disorder related symptoms of Tarentula hispanica in Synthesis Repertory - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070244
Enrollment
30
Registered
2024-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F909- Attention-deficit hyperactivity disorder, unspecified type

Interventions

Intervention1: Tarentula hispanica: Homoeopathic medicine Tarentula hispanica will be prescribed. Daily one dose of medicine will be administered orally. Follow-up of the case will be observed once in

Sponsors

Sarada Krishna Homoeopathic Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having symptomatology of Tarentula hispanica All types of diagnostic cases of Attention Deficit Hyperactivity Disorder

Exclusion criteria

Exclusion criteria: Age above 19 years Patients having other behavioral diseases Patients with severe systemic illness Children under long term medication

Design outcomes

Primary

MeasureTime frame
To find out reliability of rubrics related to ADHD representing Tarentula hispanica in synthesis repertory Timepoint: 6 months

Secondary

MeasureTime frame
Changes in symptoms of Attention Deficit Hyperactivity Disorder with respect to time in every 2 weeks Changes in the symptoms of Attention Deficit hyperactivity disorder of Tarentula hispanica in synthesis repertory every 3 months Timepoint: 6 months

Countries

India

Contacts

Public ContactDr Suman Sankar A S

Department of Repertory Sarada Krishna Homoeopathic Medical College

dissert02@gmail.com9443500675

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026